151 related articles for article (PubMed ID: 36052068)
1. Spatial biology analysis reveals B cell follicles in secondary lymphoid structures may regulate anti-tumor responses at initial melanoma diagnosis.
Therien AD; Beasley GM; Rhodin KE; Farrow NE; Tyler DS; Boczkowski D; Al-Rohil RN; Holl EK; Nair SK
Front Immunol; 2022; 13():952220. PubMed ID: 36052068
[TBL] [Abstract][Full Text] [Related]
2. Dissecting the immune landscape of tumor draining lymph nodes in melanoma with high-plex spatially resolved protein detection.
Beasley GM; Therien AD; Holl EK; Al-Rohil R; Selim MA; Farrow NE; Pan L; Haynes P; Liang Y; Tyler DS; Hanks BA; Nair SK
Cancer Immunol Immunother; 2021 Feb; 70(2):475-483. PubMed ID: 32814992
[TBL] [Abstract][Full Text] [Related]
3. [Application of sentinel lymph node biopsy in patients with melanoma].
Ren M; Kong YY; Cai X; Shen XX; Lyu JJ
Zhonghua Bing Li Xue Za Zhi; 2018 May; 47(5):360-365. PubMed ID: 29783803
[No Abstract] [Full Text] [Related]
4. The long-term results and prognostic significance of cutaneous melanoma surgery using sentinel node biopsy with triple technique.
Rutkowski P; Szydłowski K; Nowecki ZI; Sałamacha M; Goryń T; Mitręga-Korab B; Pieńkowski A; Dziewirski W; Zdzienicki M
World J Surg Oncol; 2015 Oct; 13():299. PubMed ID: 26462471
[TBL] [Abstract][Full Text] [Related]
5. Do micromorphometric features of metastatic deposits within sentinel nodes predict nonsentinel lymph node involvement in melanoma?
Frankel TL; Griffith KA; Lowe L; Wong SL; Bichakjian CK; Chang AE; Cimmino VM; Bradford CR; Rees RS; Johnson TM; Sabel MS
Ann Surg Oncol; 2008 Sep; 15(9):2403-11. PubMed ID: 18626721
[TBL] [Abstract][Full Text] [Related]
6. Idiosyncrasies of scalp melanoma.
Rigual NR; Cheney RT; Iwenofu OH; Li Q; Loree TR; Popat SR; Merzianu M
Laryngoscope; 2007 Aug; 117(8):1354-8. PubMed ID: 17592396
[TBL] [Abstract][Full Text] [Related]
7. Prediction of nonsentinel lymph node involvement in patients with a positive sentinel lymph node in malignant melanoma.
Page AJ; Carlson GW; Delman KA; Murray D; Hestley A; Cohen C
Am Surg; 2007 Jul; 73(7):674-8; discussion 678-9. PubMed ID: 17674939
[TBL] [Abstract][Full Text] [Related]
8. Characterization of Sentinel Lymph Node Immune Signatures and Implications for Risk Stratification for Adjuvant Therapy in Melanoma.
Farrow NE; Holl EK; Jung J; Gao J; Jung SH; Al-Rohil RN; Selim MA; Mosca PJ; Ollila DW; Antonia SJ; Tyler DS; Nair SK; Beasley GM
Ann Surg Oncol; 2021 Jul; 28(7):3501-3510. PubMed ID: 33205334
[TBL] [Abstract][Full Text] [Related]
9. Staging of regional lymph nodes in melanoma: a case for including nonsentinel lymph node positivity in the American Joint Committee on Cancer staging system.
Leung AM; Morton DL; Ozao-Choy J; Hari DM; Shin-Sim M; Difronzo AL; Faries MB
JAMA Surg; 2013 Sep; 148(9):879-84. PubMed ID: 23903435
[TBL] [Abstract][Full Text] [Related]
10. Accuracy of the non-sentinel node risk score (N-SNORE) in patients with cutaneous melanoma and positive sentinel lymph nodes: a retrospective study.
Feldmann R; Fink AM; Jurecka W; Rappersberger K; Steiner A
Eur J Surg Oncol; 2014 Jan; 40(1):73-6. PubMed ID: 24075029
[TBL] [Abstract][Full Text] [Related]
11. Criteria in sentinel lymph nodes of melanoma patients that predict involvement of nonsentinel lymph nodes.
Satzger I; Völker B; Meier A; Kapp A; Gutzmer R
Ann Surg Oncol; 2008 Jun; 15(6):1723-32. PubMed ID: 18389323
[TBL] [Abstract][Full Text] [Related]
12. Prediction of nonsentinel lymph node status in melanoma.
Reeves ME; Delgado R; Busam KJ; Brady MS; Coit DG
Ann Surg Oncol; 2003; 10(1):27-31. PubMed ID: 12513956
[TBL] [Abstract][Full Text] [Related]
13. Prediction of non-sentinel node status and outcome in sentinel node-positive melanoma patients.
Roka F; Mastan P; Binder M; Okamoto I; Mittlboeck M; Horvat R; Pehamberger H; Diem E
Eur J Surg Oncol; 2008 Jan; 34(1):82-8. PubMed ID: 17360144
[TBL] [Abstract][Full Text] [Related]
14. Predictors of nonsentinel lymph node positivity in patients with a positive sentinel node for melanoma.
Sabel MS; Griffith K; Sondak VK; Lowe L; Schwartz JL; Cimmino VM; Chang AE; Rees RS; Bradford CR; Johnson TM
J Am Coll Surg; 2005 Jul; 201(1):37-47. PubMed ID: 15978442
[TBL] [Abstract][Full Text] [Related]
15. Sentinel lymph nodes containing very small (<0.1 mm) deposits of metastatic melanoma cannot be safely regarded as tumor-negative.
Murali R; DeSilva C; McCarthy SW; Thompson JF; Scolyer RA
Ann Surg Oncol; 2012 Apr; 19(4):1089-99. PubMed ID: 22271204
[TBL] [Abstract][Full Text] [Related]
16. Predicting residual lymph node basin disease in melanoma patients with sentinel lymph node metastases.
Salti GI; Das Gupta TK
Am J Surg; 2003 Aug; 186(2):98-101. PubMed ID: 12885597
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and reproducibility of lymphatics mapping technique with sentinel lymph node biopsy in melanoma.
España MI; Signorini F; Marani M; Alcaraz A; Reimondez S; Romero ME; Obeide L
Cir Cir; 2019; 87(2):241-246. PubMed ID: 30768073
[TBL] [Abstract][Full Text] [Related]
18. Nonsentinel lymph node status in patients with cutaneous melanoma: results from a multi-institution prognostic study.
Pasquali S; Mocellin S; Mozzillo N; Maurichi A; Quaglino P; Borgognoni L; Solari N; Piazzalunga D; Mascheroni L; Giudice G; Patuzzo R; Caracò C; Ribero S; Marone U; Santinami M; Rossi CR
J Clin Oncol; 2014 Mar; 32(9):935-41. PubMed ID: 24516022
[TBL] [Abstract][Full Text] [Related]
19. Incidence and location of positive nonsentinel lymph nodes in head and neck melanoma.
Gyorki DE; Boyle JO; Ganly I; Morris L; Shaha AR; Singh B; Wong RJ; Shah JP; Busam K; Kraus D; Coit DG; Patel S
Eur J Surg Oncol; 2014 Mar; 40(3):305-10. PubMed ID: 24361245
[TBL] [Abstract][Full Text] [Related]
20. Factors predictive of nonsentinel lymph node involvement and clinical outcome in melanoma patients with metastatic sentinel lymph node.
Rossi CR; De Salvo GL; Bonandini E; Mocellin S; Foletto M; Pasquali S; Pilati P; Lise M; Nitti D; Rizzo E; Montesco MC
Ann Surg Oncol; 2008 Apr; 15(4):1202-10. PubMed ID: 18165880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
